Related Experiment Video
Updated: Jun 23, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
[Genetic polymorphisms of oxidation and acetylation in cancers of digestive system]
Małgorzata Barańska1, Jadwiga Skretkowicz
1Medical University of Lódź, Department of Pharmacogenetics, Poland. mbaranska@pharm.am.lodz.pl
Abstract:
Cancer diseases are the second most common cause of mortality in Poland. The cancers of digestive system: colorectal cancer, gastric cancer, pancreatic cancer and liver cancer are the first common malignant tumour. Pathogenesis of cancer diseases is connected with influence of environmental factors with individual dependent among others on detoxification enzymes. Genetic differences in the regulation, expression and activity of genes coding for phase I and phase II drug-metabolizing enzymes can be crucial factors in defining cancer of digestive system susceptibility. In this review our current knowledge about polymorphism in several of these genes is summarized.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Cancer Prevention
Some...
